Exact Mass: 470.387208
Exact Mass Matches: 470.387208
Found 500 metabolites which its exact mass value is equals to given mass value 470.387208,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
TG(8:0/8:0/8:0)
TG(8:0/8:0/8:0) belongs to the family of triradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. Their general formula is [R1]OCC(CO[R2])O[R3]. TG(8:0/8:0/8:0) is made up of one octanoyl(R1), one octanoyl(R2), and one octanoyl(R3). It is used in bakery products. Carrier for essential oils and flavours. Glycerol trioctanoate is found in cereals and cereal products. D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients Same as: D01587 Tricaprilin (Trioctanoin) is used in study for patients with mild to moderate Alzheimer's disease and has a role as an anticonvulsant and a plant metabolite[1][2].
Eburicoic acid
Eburicoic acid protects the liver from CCl4-induced hepatic damage via antioxidant and anti-inflammatory mechanisms[1]. And Eburicoic acid has antidiabetic and antihyperlipidemic effects[2]. Eburicoic acid protects the liver from CCl4-induced hepatic damage via antioxidant and anti-inflammatory mechanisms[1]. And Eburicoic acid has antidiabetic and antihyperlipidemic effects[2].
Triethylhexanoin
D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients
Ambolic acid
Ambolic acid is found in fruits. Ambolic acid is a constituent of Mangifera indica (mango)
CE(5:0)
Cholesteryl pentanoate is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). Cholesteryl esters, formed by the esterification of cholesterol with long-chain fatty acids, on one hand, are the means by which cholesterol is transported through the blood by lipoproteins, on the other, the way cholesterol itself can be accumulated in the cells. (PMID: 15939411) [HMDB] Cholesteryl pentanoate is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). Cholesteryl esters, formed by the esterification of cholesterol with long-chain fatty acids, on one hand, are the means by which cholesterol is transported through the blood by lipoproteins, on the other, the way cholesterol itself can be accumulated in the cells. (PMID: 15939411).
Momoridcin
Momoridcin is found in fruits. Momoridcin is a constituent of Momordica charantia (bitter melon) Constituent of Momordica charantia (bitter melon). Momoridcin is found in fruits.
2,3-bis(Acetyloxy)propyl icosanoate
2,3-bis(Acetyloxy)propyl icosanoate belongs to the family of Fatty Acid Esters. These are carboxylic ester derivatives of a fatty acid.
DG(8:0/17:0/0:0)
DG(8:0/17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/17:0)
DG(8:0/0:0/17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/i-17:0/0:0)
DG(8:0/i-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/i-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/i-17:0)
DG(8:0/0:0/i-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/a-17:0/0:0)
DG(8:0/a-17:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/a-17:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/a-17:0)
DG(8:0/0:0/a-17:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/15:0/0:0)
DG(10:0/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/15:0)
DG(10:0/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/i-15:0/0:0)
DG(10:0/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/i-15:0)
DG(10:0/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(10:0/a-15:0/0:0)
DG(10:0/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/a-15:0)
DG(10:0/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/13:0/0:0)
DG(12:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/13:0)
DG(12:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/13:0/0:0)
DG(i-12:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/13:0)
DG(i-12:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/a-13:0/0:0)
DG(i-12:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/a-13:0)
DG(i-12:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/i-13:0/0:0)
DG(i-12:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-12:0/0:0/i-13:0)
DG(i-12:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/i-13:0/0:0)
DG(12:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/i-13:0)
DG(12:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(12:0/a-13:0/0:0)
DG(12:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(12:0/0:0/a-13:0)
DG(12:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/12:0/0:0)
DG(13:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/12:0)
DG(13:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/12:0/0:0)
DG(i-13:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/12:0)
DG(i-13:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/i-12:0/0:0)
DG(a-13:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/i-12:0)
DG(a-13:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/12:0/0:0)
DG(a-13:0/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-13:0/0:0/12:0)
DG(a-13:0/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/i-12:0/0:0)
DG(i-13:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-13:0/0:0/i-12:0)
DG(i-13:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(13:0/i-12:0/0:0)
DG(13:0/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(13:0/0:0/i-12:0)
DG(13:0/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(15:0/10:0/0:0)
DG(15:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(15:0/0:0/10:0)
DG(15:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-15:0/10:0/0:0)
DG(i-15:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-15:0/0:0/10:0)
DG(i-15:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-15:0/10:0/0:0)
DG(a-15:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-15:0/0:0/10:0)
DG(a-15:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(17:0/8:0/0:0)
DG(17:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(17:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(17:0/0:0/8:0)
DG(17:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/8:0/0:0)
DG(i-17:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-17:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(i-17:0/0:0/8:0)
DG(i-17:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/8:0/0:0)
DG(a-17:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-17:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(a-17:0/0:0/8:0)
DG(a-17:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
N-Stearoyl Tryptophan
N-stearoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Stearic acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Stearoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Stearoyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Eburicoic acid
Oleanolic acid methyl ester
Oleanolic acid methyl ester is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Oleanolic acid methyl ester is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Oleanolic acid methyl ester can be found in common grape, which makes oleanolic acid methyl ester a potential biomarker for the consumption of this food product.
Ambolic acid
11beta-Aethoxy-alpha-amyrin = 3beta-Hydroxy-11Beta-aethoxy-Delta12-ursen
27-nor-24-oxocycloartanyl acetate|3beta-acetoxy-27-norcycloartan-3-one|3beta-Acetoxy-9beta,19-cyclo-27-nor-lanostan-24-on|3beta-acetoxy-9beta,19-cyclo-27-nor-lanostan-24-one
24-methylene-7-oxo-lanosta-8(9)-ene-3beta,25-diol|marianine
(26S)-15-deacetoxy-7,11-dihydro-26-O-methylperenniporiol
3-Ketone 28-carboxylic acid , Me ester-3alpha-3, 28-Friedelanediol
24alpha-ethyllophenol acetate|24beta-Ethyllophenol acetate
(23R,25R)-3alpha-methoxy-5alpha,9beta-lanost-7-en-26,23-olide
14alpha-Methyl-24alpha-ethylcholest-9(11)-enol acetate
14,15-seco-urs-18betaH-20(30)-en-3beta-yl acetate|plucheaursenyl acetate
24-isopropyl-5alpha-cholest-22Z-en-3beta-ol acetate
3beta-hydroxy-tirucalla-7,24c-dien-26-oic acid methyl ester|3beta-Hydroxy-tirucalla-7,24c-dien-26-saeure-methylester
3alpha-hydroxy-oleanen-(12)-oic acid-(24)-methyl ester|3alpha-Hydroxy-oleanen-(12)-saeure-(24)-methylester
D:A-Friedooleanan-29-oic acid, 3-oxo-, methyl ester, (20.alpha.)-
20-oxo-30-nortaraxastan-3beta-yl acetate|3beta-acetoxy-20-oxo-30-nortaraxastane
(25Xi)-3-oxo-tirucall-8-en-26-oic acid methyl ester|(25Xi)-3-Oxo-tirucall-8-en-26-saeure-methylester|Methyl dihydroisomasticadienoate
(+)-(20S)-20-(dimethylamino)-16alpha-hydroxy-3-(3alpha-isopropyl)-lactam-5alpha-pregn-2-en-4-one
3beta-(acetyloxy)-17beta-hydroxy-28-nor-olean-12-ene|3beta-acetoxy-28-hydroxyolean-12-ene
methyl 23-oxo-3,4-seco-8betaH-lanost-4(28),9(11)-dien-3-oate|seco-coccinic acid K
(3b,5b,10a,13a,14b,20R,22R,25S)-3-Hydroxy-22,26-epoxylanost-8-en-26-one|astrakurkurone
(24R)-3beta-acetoxystigmast-5-en-7-one|3beta-acetoxy-stigmast-5-en-7-one|3beta-acetoxysitost-5-en-7-one|3beta-acetoxystigmast-5-ene-7-one|7-keto-beta-sitosterol acetate|7-oxositost-5-en-3beta-yl acetate|7-oxositosteryl acetate
3-O-methylbetulinic acid|3beta-3-methoxylup-20(29)-en-28-oic acid|3beta-methoxybetulinic acid|3beta-methoxylup-20(29)-en-28-oic acid
(E)-N-[(20S)-20-(dimethylamino)-5alpha-pregnan-3beta-yl]-N,3,4-trimethylpent-2-enamide|saligenamide-A|Salignenamide F|salignenamide-F
C31H54N2O (470.42359139999996)
(24R)-24-hydroxy-24-vinyllathosteryl acetate|24-hydroxy-24-vinyllathosteryl acetate
4alpha,23,24-trimethylcholest-22-en-3beta-yl acetate
3beta-hydroxy-28-carboxyolean-12-ene|eupatoric acid
3-O-acetyl-29-nor-20-oxolupeol|30-nor-20-oxo-lupeol acetate|30-norlup-3beta-acetoxy-20-one|3beta-Acetoxy-30-nor-lupan-20-on|3beta-acetoxy-30-nor-lupan-20-one|3beta-Acetoxy-30-nor-lupanon-(20)|3beta-acetoxy-30-norlupan-20-one
(3beta,23R)-3-methoxy-24-methylenelanost-8-en-23-ol
(4aR)-10c-Acetoxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen|3beta-Acetoxy-18alpha.19betaH.20alphaH-ursan|3beta-Acetoxy-taraxastan|3beta-acetoxy-taraxastane|Taraxastanyl-(3beta)-acetat|taraxasterol acetate|Taraxasterylacetat
Eburcoic acid
Eburicoic acid is a natural product found in Porotheleum, Taiwanofungus camphoratus, and other organisms with data available. Eburicoic acid protects the liver from CCl4-induced hepatic damage via antioxidant and anti-inflammatory mechanisms[1]. And Eburicoic acid has antidiabetic and antihyperlipidemic effects[2]. Eburicoic acid protects the liver from CCl4-induced hepatic damage via antioxidant and anti-inflammatory mechanisms[1]. And Eburicoic acid has antidiabetic and antihyperlipidemic effects[2].
Methyl betulinate
Betulinic acid methyl ester is a triterpenoid. Methyl betulinate is a natural product found in Ixeridium gracile, Euptelea polyandra, and other organisms with data available.
Ile Ile Ile Ile
Ile Ile Ile Leu
Ile Ile Leu Ile
Ile Ile Leu Leu
Ile Leu Ile Ile
Ile Leu Ile Leu
Ile Leu Leu Ile
Ile Leu Leu Leu
Leu Ile Ile Ile
Leu Ile Ile Leu
Leu Ile Leu Ile
Leu Ile Leu Leu
Leu Leu Ile Ile
Leu Leu Ile Leu
Leu Leu Leu Ile
Leu Leu Leu Leu
(10E)-19-(3-carboxylpropyl)vitamin D3 / (10E)-19-(3-carboxylpropyl)cholecalciferol
(5E,10E)-19-(3-carboxylpropyl)vitamin D3 / (5E,10E)-19-(3-carboxylpropyl)cholecalciferol
CE(5:0)
Momoridcin
ascr#37
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,20R)-20-hydroxyhenicos-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
oscr#37
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-21-hydroxyhenicos-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
Combretanone E
A pentacyclic triterpenoid that is 9beta,19-cyclolanost-25-ene substituted by an oxo group at position 3 and hydroxy groups at positions 7 and 24. It has been isolated from the leaves of Combretum quadrangulare.
Combretanone F
A pentacyclic triterpenoid that is 9beta,19-cyclolanost-25-ene substituted by an oxo group at position 3 and hydroxy groups at positions 7 and 23. It has been isolated from the leaves of Combretum quadrangulare.
Combretanone G
A pentacyclic triterpenoid that is 9beta,19-cyclolanost-25-ene substituted by an oxo group at position 3, a hydroxy group at position 7 and a methoxy group at position 25. It has been isolated from the leaves of Combretum quadrangulare.
(10E)-19-(3-carboxylpropyl)vitamin D3
Hopane-29-acetate
A hopanoid that is hopane substituted by an acetoxy group at position 29.
2-ethyl-2-[[(1-oxoheptyl)oxy]methyl]propane-1,3-diyl bisheptanoate
(2E)-21-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicos-2-enoic acid
Methyl lansiolate
A triterpenoid that is the methyl ester of lansiolic acid. It has been isolated from the twigs of Lansium domesticum.
(2E,20R)-20-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]henicos-2-enoic acid
Tetracosanoic acid, 2-[(trimethylsilyl)oxy]-, methyl ester
C28H58O3Si (470.41549979999996)
Trimethylsilyl 24-methylenecholesterol
C31H54OSi (470.39437139999995)
Tricaprilin
D010592 - Pharmaceutic Aids > D014677 - Pharmaceutical Vehicles > D005079 - Excipients Same as: D01587 Tricaprilin (Trioctanoin) is used in study for patients with mild to moderate Alzheimer's disease and has a role as an anticonvulsant and a plant metabolite[1][2].
(1S,3R,6S,7R,8R,11S,12S,15R,16R)-15-[(2R,5S)-5,6-dimethylhept-6-en-2-yl]-6-hydroxy-7,12,16-trimethylpentacyclo[9.7.0.01,3.03,8.012,16]octadecane-7-carboxylic acid
[(2S)-3-dodecanoyloxy-2-hydroxypropyl] tridecanoate
(3-Carboxy-2-henicosanoyloxypropyl)-trimethylazanium
C28H56NO4+ (470.42091160000007)
(6S,7S,12S,16R)-6-hydroxy-7,12,16-trimethyl-15-[(2R)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.01,3.03,8.012,16]octadecane-7-carboxylic acid
[3-Carboxy-2-(10-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(19-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(13-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(9-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(17-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(16-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(8-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(7-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(6-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(12-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(3-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(4-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(14-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(18-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(15-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(11-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-Carboxy-2-(5-methylicosanoyloxy)propyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
[3-carboxy-2-[(E)-3-hydroxyicos-13-enoyl]oxypropyl]-trimethylazanium
C27H52NO5+ (470.38452820000003)
[3-carboxy-2-[(E)-3-hydroxyicos-11-enoyl]oxypropyl]-trimethylazanium
C27H52NO5+ (470.38452820000003)
Marianine
A tetracyclic triterpenoid that is lanost-8-ene substituted by hydroxy groups at positions 3 and 25, a methylidene group at position 24 and an oxo group at position 7. Isolated from the whole plant of Silybum marianum, it exhibits inhibitory activity against chymotrypsin.
2-[(3S,5R,10S,13R,14R,17R)-3-Hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid
Triptohypol D
A pentacyclic triterpenoid with formula C32H54O2, originally isolated from the root bark of Tripterygium hypoglaucum.
[(2R)-3-carboxy-2-henicosanoyloxypropyl]-trimethylazanium
C28H56NO4+ (470.42091160000007)
(1-Hydroxy-3-nonanoyloxypropan-2-yl) hexadecanoate
(1-Dodecanoyloxy-3-hydroxypropan-2-yl) tridecanoate
(1-Hydroxy-3-undecanoyloxypropan-2-yl) tetradecanoate
(1-Decanoyloxy-3-hydroxypropan-2-yl) pentadecanoate
(1-Heptanoyloxy-3-hydroxypropan-2-yl) octadecanoate
(1-Hexanoyloxy-3-hydroxypropan-2-yl) nonadecanoate
(1-Butanoyloxy-3-hydroxypropan-2-yl) henicosanoate
(1-Hydroxy-3-octanoyloxypropan-2-yl) heptadecanoate
[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] tetradecanoate
[1-carboxy-3-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
[(2S)-3-hydroxy-2-undecanoyloxypropyl] tetradecanoate
[1-carboxy-3-[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
(14Z,17Z,20Z,23Z,26Z)-dotriacontapentaenoic acid
A very long-chain omega-6 fatty acid that is dotriacontapentaenoic acid having five double bonds located at positions 14, 17, 20, 23 and 26 (the 14Z,17Z,20Z,23Z,26Z-isomer).
(17Z,20Z,23Z,26Z,29Z)-dotriacontapentaenoic acid
A very long-chain omega-3 fatty acid that is dotriacontapentaenoic acid having five double bonds located at positions 17, 20, 23, 26 and 29 (the 17Z,20Z,23Z,26Z,29Z-isomer).
Trioctanoin
A triglyceride obtained by acylation of the three hydroxy groups of glycerol by octanoic acid. Used as an alternative energy source to glucose for patients with mild to moderate Alzheimers disease.
methyl (1s,2r,4as,6as,6br,8ar,10s,12ar,12bs,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate
n-{1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}-n,3,4-trimethylpent-2-enamide
C31H54N2O (470.42359139999996)
(1r,3ar,5ar,7s,9ar,9br,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
1-{1-[1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-isopropylazetidin-2-one
(2r)-2-[(1r,3ar,5ar,7r,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid
5-(2-{7-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}propyl)-3-methyloxolan-2-one
methyl (2z,6r)-6-[(1s,3as,5ar,7r,9ar,9bs,11as)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoate
(2s,6r)-6-[(1s,3r,6s,8r,11s,12s,15r,16r)-6-hydroxy-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-2-methyl-3-methylideneheptanoic acid
methyl (2e,6r)-6-[(1s,3as,5ar,7s,9as,11as)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoate
3-[(3r,3ar,5as,6r,9ar,9br)-6,9a,9b-trimethyl-3-[(2r)-6-methylhept-5-en-2-yl]-7-(propan-2-ylidene)-octahydro-1h-cyclopenta[a]naphthalen-6-yl]propyl acetate
(2,4a,6a,8a,9,12b,14a-heptamethyl-10-oxo-tetradecahydro-1h-picen-2-yl)acetic acid
(1r,3ar,5ar,5br,7ar,9r,10r,11ar,11bs,13ar,13br)-10-methoxy-3a,5a,5b,7a,8,8,11a-heptamethyl-1-(prop-1-en-2-yl)-tetradecahydro-1h-cyclopenta[a]chrysen-9-ol
methyl (1s,2r,4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate
(1r,3ar,5ar,7s,9as,11ar)-1-[(2s,3s,5z)-3-hydroxy-5-isopropylhept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-ol
7,20-diethyl-1,7,11,16,20-pentamethylpentacyclo[13.8.0.0³,¹².0⁶,¹¹.0¹⁶,²¹]tricos-3-ene-8,19-diol
6-{7-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptan-4-ol
methyl (1s,2r,4as,6as,6br,8as,10r,12ar,12br,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylate
(3r)-1-[(1s,2r,3as,3br,5as,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-isopropylazetidin-2-one
(1r,4s,5s,8r,9r,12s,13s,16s)-8-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-16-ol
methyl 9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate
3-[6,9a,9b-trimethyl-3-(6-methylhept-5-en-2-yl)-7-(propan-2-ylidene)-octahydro-1h-cyclopenta[a]naphthalen-6-yl]propyl acetate
(1r,7r,9r,15r,21s,23s,29r,30s)-9,23-dimethyl-11,25-diazapentacyclo[19.7.1.1⁷,¹¹.0²⁵,²⁹.0¹⁵,³⁰]triacontane-8,22-dione
2-[(3s,3as,5ar,5br,7as,11as,11br,13ar,13bs)-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl]propan-2-yl acetate
6-hydroxy-7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid
(2r)-2-[(3s,3as,5ar,5br,7as,11as,11br,13ar,13bs)-5a,5b,8,8,11a,13b-hexamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl]propyl acetate
11-keto-β-boswellic acid
{"Ingredient_id": "HBIN000461","Ingredient_name": "11-keto-\u03b2-boswellic acid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36047","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
11-oxo-kansenonol
{"Ingredient_id": "HBIN000506","Ingredient_name": "11-oxo-kansenonol","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC(CC=CC(C)(C)O)C1CCC2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C","Ingredient_weight": "470.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT17037","TCMID_id": "16354","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21629618","DrugBank_id": "NA"}
12β-hydroxycoccinic acid
{"Ingredient_id": "HBIN000754","Ingredient_name": "12\u03b2-hydroxycoccinic acid","Alias": "12\u03b2-hydroxycoccinicacid","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC(CCC=C(C)C(=O)O)C1CCC2(C1(C(C=C3C2CCC4C3(CCC(=O)C4(C)C)C)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "34200;9928","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
13α,14α-epoxy-21α-methoxyserratan-3-one
{"Ingredient_id": "HBIN001127","Ingredient_name": "13\u03b1,14\u03b1-epoxy-21\u03b1-methoxyserratan-3-one","Alias": "NA","Ingredient_formula": "C31H50O3","Ingredient_Smile": "CC1(C2CCC34CC5(CCC6C(C(=O)CCC6(C5CCC3(C2(CCC1OC)C)O4)C)(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7168","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
16-oxo-3α,21β-dihydroxyserrat-14-en-24-al
{"Ingredient_id": "HBIN001937","Ingredient_name": "16-oxo-3\u03b1,21\u03b2-dihydroxyserrat-14-en-24-al","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1(C(CCC2(C1C(=O)C=C3C2CCC4C(C3)(CCC5C4(CCC(C5(C)C=O)O)C)C)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16310","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
18alpha-glycyrrhetinic acid
{"Ingredient_id": "HBIN002087","Ingredient_name": "18alpha-glycyrrhetinic acid","Alias": "J-008025; A-GLYCYRRHETINIC ACID; 1449-05-4; 18-; CG0020; 18 alpha-glycyrrhetinic acid; SMP1_000143","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C","Ingredient_weight": "470.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT18313","TCMID_id": "23166","TCMSP_id": "NA","TCM_ID_id": "12216;12217","PubChem_id": "16219451","DrugBank_id": "NA"}
19a-dihydroxy-3-oxo-l2-ursen-28oic acid
{"Ingredient_id": "HBIN002164","Ingredient_name": "19a-dihydroxy-3-oxo-l2-ursen-28oic acid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1(C)O)C)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37296","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
22α-hydroxy-3-oxoolean-12-en-29-oicacid
{"Ingredient_id": "HBIN003678","Ingredient_name": "22\u03b1-hydroxy-3-oxoolean-12-en-29-oicacid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1(C2CCC3(C(C2(CCC1=O)C)CC=C4C3(CCC5(C4CC(CC5O)(C)C(=O)O)C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10577","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2,3-dihydroxy-5,12-oleanadien-28-oic acid; (2α,3α)-form
{"Ingredient_id": "HBIN004048","Ingredient_name": "2,3-dihydroxy-5,12-oleanadien-28-oic acid; (2\u03b1,3\u03b1)-form","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "NA","Ingredient_weight": "470.68","OB_score": "NA","CAS_id": "142287-78-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8937","PubChem_id": "NA","DrugBank_id": "NA"}
24,25-epoxy-23-hydroxyprotost-13(17)-ene-3,16-dione; (23s,24r)-form
{"Ingredient_id": "HBIN004194","Ingredient_name": "24,25-epoxy-23-hydroxyprotost-13(17)-ene-3,16-dione; (23s,24r)-form","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "NA","Ingredient_weight": "470.68","OB_score": "NA","CAS_id": "119157-56-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8752","PubChem_id": "NA","DrugBank_id": "NA"}
24(e)-3,4-seco-9βh-lanosta-4(28),7,24-triene-3,26-dioicacid
{"Ingredient_id": "HBIN004373","Ingredient_name": "24(e)-3,4-seco-9\u03b2h-lanosta-4(28),7,24-triene-3,26-dioicacid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC(CCC=C(C)C(=O)O)C1CCC2(C1(CCC3C2=CCC(C3(C)CCC(=O)O)C(=C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19607","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(24e)-3,4-secodammara-4(28),20,24-trien-3,26-dioicacid
{"Ingredient_id": "HBIN004374","Ingredient_name": "(24e)-3,4-secodammara-4(28),20,24-trien-3,26-dioicacid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC(=C)C1CCC2(C(C1(C)CCC(=O)O)CCC3C2(CCC3C(=C)CCC=C(C)C(=O)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19594","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(25r)-3α-hydroxy-23-oxo-9,16-lanostadien-26-oic-acid
{"Ingredient_id": "HBIN004730","Ingredient_name": "(25r)-3\u03b1-hydroxy-23-oxo-9,16-lanostadien-26-oic-acid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC(CC(=O)CC(C)C(=O)O)C1=CCC2(C1(CC=C3C2CCC4C3(CCC(C4(C)C)O)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10570","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(25r)-3β-hydroxy-23-oxo-9,16-lanostadien-26-oicacid
{"Ingredient_id": "HBIN004732","Ingredient_name": "(25r)-3\u03b2-hydroxy-23-oxo-9,16-lanostadien-26-oicacid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC(CC(=O)CC(C)C(=O)O)C1=CCC2(C1(CC=C3C2CCC4C3(CCC(C4(C)C)O)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10571","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
29-hydroxy-3-oxo-olean-12-en-28-oic acid
{"Ingredient_id": "HBIN005092","Ingredient_name": "29-hydroxy-3-oxo-olean-12-en-28-oic acid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1(C2CCC3(C(C2(CCC1=O)C)CC=C4C3(CCC5(C4CC(CC5)(C)CO)C(=O)O)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "27117","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,24-dioxo-fridelan-29-oic acid
{"Ingredient_id": "HBIN007022","Ingredient_name": "3,24-dioxo-fridelan-29-oic acid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)C=O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25825","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,24-dioxo-friedelan-29-oicacid
{"Ingredient_id": "HBIN007023","Ingredient_name": "3,24-dioxo-friedelan-29-oicacid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15190","TCMID_id": "6467","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3a)-3-hydroxy-Urs-12-en-28-oic acid, methyl ester
{"Ingredient_id": "HBIN007850","Ingredient_name": "(3a)-3-hydroxy-Urs-12-en-28-oic acid, methyl ester","Alias": "NA","Ingredient_formula": "C31H50O3","Ingredient_Smile": "NA","Ingredient_weight": "470.73","OB_score": "13.97301097","CAS_id": "915-32-2","SymMap_id": "SMIT06996","TCMID_id": "NA","TCMSP_id": "MOL005204","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-hydroxy-29(or 30)-al-olean-12-en-28-oicacid
{"Ingredient_id": "HBIN008227","Ingredient_name": "3\u03b2-hydroxy-29(or 30)-al-olean-12-en-28-oicacid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9774","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β-hydroxy-5α-cycloart-24(31)-en-28-oicacid
{"Ingredient_id": "HBIN008232","Ingredient_name": "3\u03b2-hydroxy-5\u03b1-cycloart-24(31)-en-28-oicacid","Alias": "NA","Ingredient_formula": "C31H50O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9951","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-hydroxy-2-oxo-3-fridelen-20alpha-carboxylic acid
{"Ingredient_id": "HBIN008644","Ingredient_name": "3-hydroxy-2-oxo-3-fridelen-20alpha-carboxylic acid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1=C(C(=O)CC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31246","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-hydroxy-2-oxo-3-friedelen-20α-carboxylicacid
{"Ingredient_id": "HBIN008645","Ingredient_name": "3-hydroxy-2-oxo-3-friedelen-20\u03b1-carboxylicacid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1=C(C(=O)CC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15895","TCMID_id": "10565","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-oxo-19α-hydroxyurs-12-en-28-oic acid
{"Ingredient_id": "HBIN009398","Ingredient_name": "3-oxo-19\u03b1-hydroxyurs-12-en-28-oic acid","Alias": "3-oxo-19\u03b1-hydroxyurs-12-en-28-oicacid","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1(C)O)C)C(=O)O","Ingredient_weight": "634.54","OB_score": "3.013720692","CAS_id": "NA","SymMap_id": "SMIT00874","TCMID_id": "16347","TCMSP_id": "MOL005861","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-oxo-23-dihydroxycycloart-24-en-26-oicacid
{"Ingredient_id": "HBIN009402","Ingredient_name": "3-oxo-23-dihydroxycycloart-24-en-26-oicacid","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC(CC(C=C(C)C(=O)O)O)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(=O)C5(C)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16306","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-oxo-ganoderic acid Z
{"Ingredient_id": "HBIN013433","Ingredient_name": "7-oxo-ganoderic acid Z","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC(CCC=C(C)C(=O)O)C1CCC2(C1(CCC3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C","Ingredient_weight": "470.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37157","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "134715203","DrugBank_id": "NA"}
acacicacid lactone
{"Ingredient_id": "HBIN014312","Ingredient_name": "acacicacid lactone","Alias": "NA","Ingredient_formula": "C30H46O4","Ingredient_Smile": "CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CC(C26CC1OC6=O)O)C)C)(C)C)O)C)C","Ingredient_weight": "470.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "59","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "6712546","DrugBank_id": "NA"}
ambolic acid
{"Ingredient_id": "HBIN015826","Ingredient_name": "ambolic acid","Alias": "ambolicacid","Ingredient_formula": "C31H50O3","Ingredient_Smile": "CC(CCC(=C)C(C)C(=O)O)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C","Ingredient_weight": "470.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25645;1024","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101286241","DrugBank_id": "NA"}
(2e)-6-[(3s,3ar,5as,6s,7s,9ar,9br)-6-(2-carboxyethyl)-6,9a,9b-trimethyl-7-(prop-1-en-2-yl)-decahydrocyclopenta[a]naphthalen-3-yl]-2-methylhepta-2,6-dienoic acid
8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-9-oxo-1-(prop-1-en-2-yl)-tetradecahydro-1h-cyclopenta[a]chrysene-3a-carboxylic acid
methyl (4ar,6as,6br,8as,10s,12ar,12bs,14bs)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate
(1r,3s,5r,10s,14s,15s,18s)-15-[(2s,4r)-4-[(2s)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-6,6,10,14,18-pentamethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-7-one
(1r,4s,5s,8s,10s,13s,14s,17r,18r,19s,22s)-10,22-dihydroxy-4,5,9,9,13,19-hexamethyl-20-methylidene-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-23-one
6-(1-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3,6-dimethyloxan-2-one
(2e)-6-[(1r,2s,5r,6s,9r,10r,13r,15s)-15-hydroxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl]-2-methylhepta-2,6-dienoic acid
20-hydroxy-8,8,14,15,19,19-hexamethyl-21-oxahexacyclo[18.2.2.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹]tetracos-4-ene-11-carboxylic acid
(3r,5r)-5-[(2r)-2-[(1s,3r,6r,8r,11s,12s,15r,16r)-6-methoxy-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]propyl]-3-methyloxolan-2-one
7-hydroxy-9a-(hydroxymethyl)-11a-methyl-1-(6-methyl-5-methylidenehept-3-en-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate
(1s,2s,5r)-2-[(2r,5z)-5-{4-[(3z,6r)-6-[(1s,2s,3r)-2-hydroxy-3-(prop-1-en-2-yl)cyclopentyl]oxan-3-ylidene]butylidene}oxan-2-yl]-5-(prop-1-en-2-yl)cyclopentan-1-ol
12a-formyl-10-hydroxy-2,4a,6a,6b,9,9-hexamethyl-3,4,5,6,7,8,8a,10,11,12,12b,13,14,14a-tetradecahydropicene-2-carboxylic acid
(4as,6as,6br,8s,8ar,12ar,12br,14bs)-8-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid
(1r,4s,5r,10s,13r,18s,20s,21s)-10-hydroxy-20-(hydroxymethyl)-4,5,9,9,13,20-hexamethyl-22-oxahexacyclo[19.2.1.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-16-en-23-one
(4as,6as,6br,8r,8ar,12ar,12br,14bs)-8-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid
(1s,2s,6s,11s,14s,15r,18r,20r)-20-hydroxy-8,8,14,15,19,19-hexamethyl-21-oxahexacyclo[18.2.2.0¹,¹⁸.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹]tetracos-4-ene-11-carboxylic acid
14-ethoxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol
n-[(1r,3r,6r,8s,11s,12s,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-7,7,12,16-tetramethyl-18-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]butanimidic acid
12a-(hydroxymethyl)-2,4a,6a,6b,9,9-hexamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b,13,14b-dodecahydro-1h-picene-2-carboxylic acid
(1s,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-1-isopropyl-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
(2e,6r)-6-[(3r,3ar,5as,6s,7s,9br)-6-(2-carboxyethyl)-3a,6,9b-trimethyl-7-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,5ah,7h,8h-cyclopenta[a]naphthalen-3-yl]-2-methylhept-2-enoic acid
2-{2,7-dihydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylhept-5-enoic acid
6-{15-hydroxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.0¹,¹³.0²,¹⁰.0⁵,⁹]nonadecan-6-yl}-2-methylhepta-2,6-dienoic acid
(1r,3ar,5ar,5br,7ar,9s,11ar,11br,13ar,13bs)-1-acetyl-3a,5a,5b,8,8,11a-hexamethyl-hexadecahydrocyclopenta[a]chrysen-9-yl acetate
methyl (2z,6r)-6-[(1s,3as,5ar,7s,9ar,9bs,11as)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoate
(3s,6ar,6bs,8ar,11r,12s,14r,14bs)-14-ethoxy-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-ol
9,10-dihydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-cyclopenta[a]chrysene-3a-carboxylic acid
ethyl 10-hydroxy-2,2,6b,9,9,12a-hexamethyl-3,4,5,6,7,8,8a,10,11,12,12b,13,14,14b-tetradecahydro-1h-picene-4a-carboxylate
(1r,3ar,5ar,9as,11ar)-1-[(1s)-1-[(2s,5r)-6-methoxy-5-methyloxan-2-yl]ethyl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-one
methyl 3-[12-(3-hydroxyprop-1-en-2-yl)-4,8-dimethyl-5-(6-methylhept-5-en-2-yl)tetracyclo[7.5.0.0¹,¹³.0⁴,⁸]tetradecan-13-yl]propanoate
(1r,3ar,5as,6s,7s,9as,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-6,9a,11a-trimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate
2-[(1z,2r,3s,4s)-4-hydroxy-2-(3-hydroxypropyl)-3,4-dimethyl-3-[(3e,5e)-4-methyl-6-[(1r,3s)-2,2,3-trimethyl-6-methylidenecyclohexyl]hexa-3,5-dien-1-yl]cyclohexylidene]propanal
9,23-dimethyl-11,25-diazapentacyclo[19.7.1.1⁷,¹¹.0²⁵,²⁹.0¹⁵,³⁰]triacontane-8,22-dione
19-methoxy-3,7,7,11,16,20,20-heptamethyl-24-oxahexacyclo[13.8.1.0¹,¹⁵.0³,¹².0⁶,¹¹.0¹⁶,²¹]tetracosan-8-one
(1r,7s,9s,15r,21s,23s,29r,30r)-9,23-dimethyl-11,25-diazapentacyclo[19.7.1.1⁷,¹¹.0²⁵,²⁹.0¹⁵,³⁰]triacontane-8,22-dione
(3r)-1-[(1s,2s,3as,3br,5ar,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-2-hydroxy-9a,11a-dimethyl-6-oxo-1h,2h,3h,3ah,3bh,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-isopropylazetidin-2-one
(2e)-n-[(1s,3as,3br,5as,7s,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]-n,3,4-trimethylpent-2-enamide
C31H54N2O (470.42359139999996)